Evidence map›Paper›PMID 17549482›Full record

ArticleRheumatology international2007

Pro-inflammatory cellular immune response in Behçet's disease.

Ayla Kulaber, Ilknur Tugal-Tutkun, Sibel P Yentür, Gülşen Akman-Demir, Fumio Kaneko, Ahmet Gül, Güher Saruhan-Direskeneli

Abstract read
PubMed Publisher
In one paragraph

Article in Rheumatology international, 2007. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 21 papers.

0numbers the graph read from it
0cells of the map it votes in
21citing papers in PubMed
1.8field-weighted citation impact, top 16% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

21 citing papers in PubMed, 62 citations in OpenAlex.

  1. Trial
  2. Article
  3. Article
  4. Review
  5. Heat Shock Proteins in Behçet SyndromeBalkan medical journal · 2023
    Review
  6. Article
  7. Cascade of immune mechanism and consequences of inflammatory disorders.Phytomedicine : international journal of phytotherapy and phytopharmacology · 2021
    Review
  8. Review
  9. Cytokine, C-Reactive Protein, and Heat Shock Protein mRNA Expression Levels in Patients with Active Behçet's Uveitis.Medical science monitor : international medical journal of experimental and clinical research · 2018
    Article
  10. Article
  11. Morbus Behçet - a rare disease in Central Europe.Archives of medical science : AMS · 2015
    Article
  12. Review
  13. Helicobacter pylori and skin autoimmune diseases.World journal of gastroenterology · 2014
    Review
  14. Review
  15. Article
  16. Article
  17. Article
  18. Potential Infectious Etiology of Behçet's Disease.Pathology research international · 2012
    Article
  19. Article
  20. [Autoinflammatory diseases as cause of wound healing defects].Der Hautarzt; Zeitschrift fur Dermatologie, Venerologie, und verwandte Gebiete · 2011
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 2 institutions in 2 countries.

Ayla KulaberDepartment of Physiology, Istanbul Medical Faculty, Istanbul University, Istanbul, Turkey.
Ilknur Tugal-Tutkun
Sibel P Yentür
Gülşen Akman-Demir
Fumio Kaneko
Ahmet Gül
Güher Saruhan-Direskeneli
Istanbul University · TRFukushima Medical University · JP

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Several proteins are investigated as candidate auto-antigens in the pathogenesis of Behçet's disease (BD). This study aimed to screen the cellular responses to auto-antigen (alphaB-crystallin, alphaBC), and microorganism (Streptococcus sangius KTH-1 BES-1 protein) derived peptides as well as to isopentenyl pyrophosphate (IPP). Peripheral blood mononuclear cells (PBMC) from 22 BD patients and 22 healthy controls (HC) were stimulated in vitro with alphaBC, BES-1 peptides, IPP and PPD and induced proliferation as well as the secreted interleukin (IL)-12 and interferon (IFN)-gamma production levels were measured. We did not observe any significant difference in cellular proliferation between BD patients and HC. Induction of IL-12 secretion with alphaBC was stronger in BD patients (P = 0.04) and in the disease subgroup with uveitis (P = 0.027) compared the HC. When responses to PPD were compared, proliferation of PMBC was lower (P = 0.03), whereas IL-12 secretion was higher in BD (P = 0.04) as well as in patients under colchicum treatment (P = 0.04) and with vascular involvement (P = 0.006) compared to HC. BES-1(373-385 )peptide induced also higher IL-12 productions by PBMC of BD patients (P = 0.017) and of patients with uveitis (P = 0.013). Finally, IPP stimulated higher IL-12 secretions from PBMC in BD patients (P = 0.035) and in patients with (P = 0.02) or without (P = 0.017) uveitis or arthritis (P = 0.04), under colchicum treatment (P = 0.01) or not receiving any immunosuppressive treatment (P = 0.007) compared to HC. These results suggest a more prominent pro-inflammatory cytokine secretion from PBMC in BD patients compared to HC in response to various antigens including alphaBC protein, BES-1(373-385), IPP and PPD.

Indexed as

Adultalpha-Crystallin B ChainAntigens, BacterialAzathioprineBehcet SyndromeCell ProliferationCells, CulturedColchicineFemaleGlucocorticoidsHemiterpenesHumansInterferon-gammaInterleukin-12Leukocytes, MononuclearLymphocyte Activationalpha-Crystallin B ChainAntigens, BacterialAzathioprineBES-1 protein, Streptococcus sanguisColchicineGlucocorticoidsHemiterpenesInterferon-gammaInterleukin-12isopentenyl pyrophosphateOrganophosphorus Compounds

Identifiers

PMID17549482
OpenAlexW1980139888

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.